Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
Compared with control therapy, the Janus kinase inhibitor ruxolitinib leads [...]
| Categories: hematology-oncology, newsletter
Compared with control therapy, the Janus kinase inhibitor ruxolitinib leads to greater overall response, failure-free survival, and symptom response for glucocorticoid-refractory or -dependent chronic graft-versus-host […]
Compared with control therapy, the Janus kinase inhibitor ruxolitinib leads [...]
August 11 is Annual Medical Checkup Day, a yearly reminder [...]
The histone deacetylase (HDAC) inhibitor remetinostat may be effective for [...]
A systematic review of clinical data used in economic evaluations [...]
Cancer surgeries at National Cancer Institute (NCI) centers are associated [...]
A study shows that fluorescence optical imaging (FOI) can successfully [...]
Risk of blood clots or thrombosis during intravenous (IV) chemotherapy [...]
In a joint press release, the National Kidney Foundation (NKF) [...]
For women with triple-negative breast cancer (TNBC), statin use after [...]
Patients with decompensated cirrhosis and ascites may develop type 1 [...]
One year of adjuvant olaparib should be offered to patients [...]
Patients with kidney failure on maintenance dialysis are particularly vulnerable [...]
Airway Pressure Release Ventilation (APRV) is a viable mode of [...]
A study further highlighted the international effect of COVID-19, as [...]
Patients with chronic kidney disease (CKD) are commonly advised to [...]
A case report published in Radiology Case Reports highlighted the [...]
For gynecologic oncology patients, unmet social needs are associated with [...]
There appears to be a survival benefit for individuals with [...]
ANNA 2021 National Symposium The prevalence of cardiovascular disease is [...]
A new study shows that hospitalized patients with SARS-CoV-2 (COVID-19) [...]
This week, the U.S. Food and Drug Administration (FDA) approved [...]
ANNA 2021 National Symposium Primary hyperoxaluria type 1 (PH1) is [...]
There is a familial risk for hematologic malignancies, according to [...]
A new study shows that intracardiac echocardiography (ICE) and its [...]
NKF Spring Clinical Meetings Patients with non-dialysis dependent chronic kidney [...]
Patients with colon cancer who are in the U.S. military [...]
The findings of a new study suggest that people who [...]
ANNA 2021 National Symposium During a virtual poster session at [...]
Patients with COVID-19 commonly develop acute kidney injury (AKI). However, [...]